Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of triple-negative breast cancer

Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer

How effective is accelerated partial breast irradiation in patients with early breast cancer?

Addition of S-1 to post-operative endocrine therapy for patients with hormone receptor-positive HER2-negative breast cancer

QUANTUM-R: Transfusion independence in patients with FLT3-ITD-mutated R/R AML treated with quizartinib or salvage chemotherapy

Ibrutinib plus venetoclax for the first-line treatment of CLL/SLL: Results from the CAPTIVATE study

FiTNEss: Investigating frailty-adjusted therapy in transplant non-eligible patients with NDMM

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results

Benefits of apixaban among venous thromboembolism patients with active cancer

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints

Eligibility criteria in acute myeloid leukaemia clinical trials